DERMAHAN UV SUN
DERMAHAN UV SUN is an FDA drug label for the active ingredient ADENOSINE, NIACINAMIDE manufactured by LAON COMMERCE co ltd administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230417.
- Generic name
- ADENOSINE, NIACINAMIDE
- Manufacturer
- LAON COMMERCE co ltd
- Product type
- HUMAN OTC DRUG
- Route
- TOPICAL
- Dosage form
- N/A
- NDC
- 82083-0016
- Application
- N/A
- Label effective
- 20230417
Active ingredients
Indications & Usage
In the last step of basic care, apply an appropriate amount to the face, neck, arms, legs, etc. that are prone to UV exposure.
Dosage & Administration
topical use only
Contraindications
Not available.
Warnings
1. If there are any abnormal symptoms or side effects such as red spots, swelling, or itching when using cosmetics or direct sunlight after use, consult a specialist. 2. Refrain from using it on injured areas, etc. 3. Precautions for storage and handling A) Keep it out of reach of children. B) Keep away from direct sunlight 3. Protects the skin from UV rays(SPF50+/PA++++) Helps whiten the skin. It helps to improve wrinkles on the skin.
Adverse Reactions
Not available.